Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 3
- Page suivante
Title | Authors | Year | Journal Trier par ordre décroissant | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Platelet concentrates from fresh or overnight-stored blood, an international study | Dijkstra-Tiekstra MJ, van der Meer PF, Cardigan R, Devine D, Prowse C, Sandgren P, de Wildt-Eggen J, for the Biomedical Excellence for Safer Transfusion C | 2011 | Transfusion | View Platelet concentrates from fresh or overnight-stored blood, an international study | Blood operators | New or improved product or process |
Closing in on DEHP-free red blood cell concentrate containers | Almizraq RJ, Acker J | 2018 | Transfusion | View Closing in on DEHP-free red blood cell concentrate containers | Researchers | New or improved product or process |
Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Shih AW, Morrison D, Sekhon AS, Lin Y, Charge S, Chipperfield K, Beaveridge J | 2020 | Transfusion | View Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Health care providers | Other |
Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Alabdullatif M, Osman IE, Alrasheed M, Ramirez-Arcos S, Alyousef M, Althawadi S, Alhumiadan H | 2021 | Transfusion | View Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Researchers | New or improved product or process |
A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Drews SJ, Devine DV, McManus J, Mendoza E, Manguiat K, Wood H, Girardin R, Dupuis A, McDonough K, Drebot M | 2021 | Transfusion | View A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Researchers | Basic research |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME) | Webert KE, Arnold DM, Lui Y, Carruthers J, Arnold E, Heddle NM | 2012 | Transfusion | View A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME) | Health care providers | Clinical research |
Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes | Michelis FV, Branch DR, Scovell I, Bloch E, Pendergrast J, Lipton JH, Cserti-Gazdewich CM | 2014 | Transfusion | View Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes | Health care providers | Clinical research |
An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia | Sholapur NS, Hamilton K, Butler L, Heddle NM, Arnold DM | 2016 | Transfusion | View An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia | Researchers | Clinical research |
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcgammaRIIb genetic disruption | Crow AR, Amash A, Lazarus AH | 2014 | Transfusion | View CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcgammaRIIb genetic disruption | Researchers | Basic research |
Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study | Cardigan R, Van der Meer PF, Pergande C, Cookson P, Baumann-Baretti B, Cancelas JA, Devine D, Gulliksson H, Vassallo R, de Wildt-Eggen J | 2011 | Transfusion | View Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study | Blood operators | New or improved product or process |
Cryopreservation of adult unrelated donor products in hematopoietic cell transplantation: the OneMatch experience and systematic review of the literature | Aziz J, Morris G, Rizk M, Shorr R, Mercer D, Young K, Allan D | 2017 | Transfusion | View Cryopreservation of adult unrelated donor products in hematopoietic cell transplantation: the OneMatch experience and systematic review of the literature | Researchers | Clinical research |
Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Kou Y, Halpenny M, Elmoazzen H, Ramirez-Arcos S | 2018 | Transfusion | View Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Researchers | New or improved product or process |
Impact of a 5-year deferral from blood donation for men who have sex with men | O'Brien SF, Osmond L, Fan W, Yi Q-L, Goldman M | 2015 | Transfusion | View Impact of a 5-year deferral from blood donation for men who have sex with men | Blood operators | Benchmarking and standard setting |
Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions | Hume HA, Ddungu H, Angom R, Baluku H, Kajumbula H, Kyeyune-Byabazaire D, Orem J, Ramirez-Arcos S, Tobian AA | 2016 | Transfusion | View Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions | Researchers | Basic research |
Supernatant reduction of stored gamma?irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates | Serrano K, Pambrun C, Levin E, Devine DV | 2017 | Transfusion | View Supernatant reduction of stored gamma?irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates | Health care providers | New or improved product or process |
Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a | Solh Z, Breakey V, Murthy P, Smith JW, Arnold DM | 2016 | Transfusion | View Triplets with neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1a | Health care providers | Clinical research |
Immunotherapy: the good, the bad, the ugly, and the really ugly | Branch DR | 2019 | Transfusion | View Immunotherapy: the good, the bad, the ugly, and the really ugly | Researchers | Clinical research |
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, AuBuchon J, Flegel W, Reeve D, Devine D, Cohn C, Custer B, Goodrich R, Benjamin RJ, Razatos A, Cancelas J, Wagner S, Maclean M, Gelderman M, Cap A, Ness P | 2019 | Transfusion | View Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Researchers | New or improved product or process |
Blood donation and testosterone replacement therapy | Chin-Yee B, Lazo-Langner A, Butler-Foster T, Hsia C, Chin-Yee I | 2017 | Transfusion | View Blood donation and testosterone replacement therapy | Health care providers | Clinical research |
Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Shehata N, Forster A, Lawrence N, Rothwell DM, Fergusson D, Tinmouth A, Wilson K | 2014 | Transfusion | View Changing trends in blood transfusion: an analysis of 244,013 hospitalizations | Health care providers | Clinical research |
Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma | Hannon JL, Clarke G | 2015 | Transfusion | View Transfusion management of patients receiving daratumumab therapy for advanced plasma cell myeloma | Health care providers | Clinical research |
Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method | Schubert P, Culibrk B, Karwal S, Serrano K, Levin E, Bu D, Bhakta V, Sheffield WP, Goodrich RP, Devine DV | 2014 | Transfusion | View Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method | Researchers | Basic research |
Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Haw J, Polzer J, Devine DV | 2019 | Transfusion | View Contextual factors influencing donor recruitment and cord blood collection: perspectives of frontline staff of the Canadian Blood Services' Cord Blood Bank | Researchers | New or improved product or process |
Hypothermic storage of leukoreduced red blood cells for greater than 21-days is a safe alternative to irradiation | Mykhailova O, Turner TR, Olafson C, Howell A, Nahirniak SN, Wizniak J, Gerges HYN, Baldwin T, Clarke G, Acker JP | 2021 | Transfusion | View Hypothermic storage of leukoreduced red blood cells for greater than 21-days is a safe alternative to irradiation | Researchers | New or improved product or process |
Multicenter observational study evaluating the impact of platelet transport bags on product wastage | Kron A, Vijenthira S, Pendergrast J, Modi D, McLaren A, MacDonald A, Armali C, Cserti-Gazdewich C, Smith E, Quest G, Gabanowicz K, Lieberman L, Aseltine L, Sani L, Roche M, DeOliviera M, Yu P, Fazari S, Patel S, Lin Y, Kelly Z, Callum J | 2021 | Transfusion | View Multicenter observational study evaluating the impact of platelet transport bags on product wastage | Researchers | New or improved product or process |
Ex vivo hemostatic and immuno-inflammatory profiles of freeze-dried plasma | Peng HT, Rhind SG, Devine D, Jenkins C, Beckett A | 2021 | Transfusion | View Ex vivo hemostatic and immuno-inflammatory profiles of freeze-dried plasma | Researchers | Clinical research |
Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Peng HT, Rhind SG, Moes K, Devine D, Jenkins C, Beckett A | 2022 | Transfusion | View Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Health care providers | New or improved product or process |
Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH | 2018 | Transfusion | View Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Health care providers | Clinical research |
BEST-TEST2: assessment of hematology trainee knowledge of transfusion medicine | Lin Y, Tinmouth A, Mallick R, Haspel RL, for the BEST-TEST2 Investigators | 2015 | Transfusion | View BEST-TEST2: assessment of hematology trainee knowledge of transfusion medicine | Other | Other |
Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer no to risk questions | O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Huang M, Ndao M, Fearon MA | 2014 | Transfusion | View Evaluation of selective screening of donors for antibody to Trypanosoma cruzi: seroprevalence of donors who answer no to risk questions | Blood operators | New or improved product or process |
Making good policy decisions: a discipline we cannot afford to ignore | Leach Bennett J | 2015 | Transfusion | View Making good policy decisions: a discipline we cannot afford to ignore | Blood operators | Other |
Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Tchir JD, Acker JP, Holovati JL | 2013 | Transfusion | View Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | Researchers | Basic research |
Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease | Kanias T, Sinchar D, Osei-Hwedieh D, Baust JJ, Jordan A, Zimring JC, Waterman HR, de Wolski KS, Acker JP, Gladwin MT | 2016 | Transfusion | View Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease | Researchers | Basic research |
Validation of sterility testing of cord blood: Challenges and results | Ramirez-Arcos S, Kou Y, Yang L, Perkins H, Taha M, Halpenny M, Elmoazzen H | 2015 | Transfusion | View Validation of sterility testing of cord blood: Challenges and results | Blood operators | New or improved product or process |
Inhibition of ice recrystallization during cryopreservation of cord blood grafts improves platelet engraftment | Jahan S, Adam MK, Manesia JK, Doxtator E, Ben RN, Pineault N | 2020 | Transfusion | View Inhibition of ice recrystallization during cryopreservation of cord blood grafts improves platelet engraftment | Researchers | Basic research |
A suspected septic transfusion reaction associated with posttransfusion contamination of a platelet pool by vancomycin-resistant Enterococcus faecium | Drews SJ, Lesley P, Detsky ME, Distefano L, Ilagan C, Mehta S, McGeer A, Shehata N, Skeate R, Ramirez-Arcos S | 2020 | Transfusion | View A suspected septic transfusion reaction associated with posttransfusion contamination of a platelet pool by vancomycin-resistant Enterococcus faecium | Researchers | Basic research |
Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development | Hajjaj OI, Clarke G, Lieberman L, Canadian Obstetrical Pediatric Transfusion Network | 2022 | Transfusion | View Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development | Health care providers | Benchmarking and standard setting |
Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Hofkirchner A, Kohut T, O'Brien SF, Fisher WA | 2022 | Transfusion | View Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Researchers | MSM research |
Tips, tricks, and thoughts on the future of prehospital blood transfusions | Yazer MH, Beckett A, Corley J, Devine DV, Studer NM, Taylor AL, Ward KR, Cap AP | 2022 | Transfusion | View Tips, tricks, and thoughts on the future of prehospital blood transfusions | Health care providers | Clinical research |
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Poglod R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH | 2018 | Transfusion | View An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Health care providers | Clinical research |
Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services | Levin E, Jenkins C, Culibrk B, Gyongyossy-Issa MIC, Serrano K, Devine DV | 2012 | Transfusion | View Development of a quality monitoring program for platelet components: a report of the first four years' experience at Canadian Blood Services | Blood operators | New or improved product or process |
Enhancing blood donor skin disinfection using natural oils | Alabdullatif M, Boujezza I, Mekni M, Taha M, Kumaran D, Yi QL, Landoulsi A, Ramirez-Arcos S | 2017 | Transfusion | View Enhancing blood donor skin disinfection using natural oils | Researchers | New or improved product or process |
Frequency and risk factors for donor reactions in an anonymous blood donor survey | Goldman M, Osmond L, Yi QL, Cameron-Choi K, O'Brien SF | 2012 | Transfusion | View Frequency and risk factors for donor reactions in an anonymous blood donor survey | Blood operators | Other |
Nucleic acid extraction from buccal tissue for prediction of red blood cell phenotype | Berardi P, Cote J, Clarke G, Scalia V, Liwski R, Goldman M | 2017 | Transfusion | View Nucleic acid extraction from buccal tissue for prediction of red blood cell phenotype | Researchers | New or improved product or process |
Seroprevalence of Babesia microti infection in Canadian blood donors | O'Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi Q-L, Fearon MA | 2016 | Transfusion | View Seroprevalence of Babesia microti infection in Canadian blood donors | Blood operators | New or improved product or process |
Impact of product platelet count reduction on platelet demand in Canada | Devine DV | 2022 | Transfusion | View Impact of product platelet count reduction on platelet demand in Canada | Blood operators | Benchmarking and standard setting |
A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Barty RL, Gagliardi K, Owens W, Lauzon D, Scheuermann S, Liu Y, Wang G, Pai M, Heddle NM | 2015 | Transfusion | View A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework | Health care providers | Benchmarking and standard setting |
Anti-A and anti-B: what are they and where do they come from? | Branch DR | 2015 | Transfusion | View Anti-A and anti-B: what are they and where do they come from? | Researchers | Other |
Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blake JT, Hardy M, Delage G, Myhal G | 2013 | Transfusion | View Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blood operators | New or improved product or process |